Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO ASSETS RATIO
N/A
ADARx Pharmaceuticals, Inc.
Market Cap
$1.88B
Debt to Assets Ratio
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | $1.88B | N/A |
| Target Hospitality Corp. (TH)vs › | $1.86B | 0.01% |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.85B | 0.23% |
| Midera Food Processing, Inc. (MFP)vs › | $1.94B | 0.19% |
| Cimpress plc (CMPR)vs › | $1.82B | 0.79% |
| Werner Enterprises, Inc. (WERN)vs › | $1.98B | 0.30% |
| Allient Inc. (ALNT)vs › | $2.02B | 0.33% |
| Neutron Holdings, Inc. (LIME)vs › | $1.76B | N/A |
| Arxis, Inc. Class A Common Stock (ARXS)vs › | $2.03B | 0.25% |
| Hub Group, Inc. (HUBG)vs › | $1.71B | 0.17% |
Debt/Assets
N/A
Debt/Equity
N/A
Current Ratio
N/A
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
